Associate Director, Portfolio Operations Excellence
Revolution Medicines
Summary
Reporting directly to the Senior Director, National Portfolio Field Excellence, the Associate Director, National Portfolio Field Excellence leads the team responsible for Revolution Medicines' U.S. commercial regional congress, sponsorship, peer-to-peer speaker program, and speaker contracting operations across the portfolio. This leader drives the operating model that underpins these programs—intake, governance, vendor management, budget stewardship, and compliance—enabling brand and field teams to execute with speed, consistency, and confidence in preparation for anticipated launches and in line brands.
Job description
The Opportunity
Reporting directly to the Senior Director, National Portfolio Field Excellence, the Associate Director, National Portfolio Field Excellence leads the team responsible for Revolution Medicines' U.S. commercial regional congress, sponsorship, peer-to-peer speaker program, and speaker contracting operations across the portfolio. This leader drives the operating model that underpins these programs—intake, governance, vendor management, budget stewardship, and compliance—enabling brand and field teams to execute with speed, consistency, and confidence in preparation for anticipated launches and in line brands.
This is a portfolio-level position rather than an asset-specific one. It requires a leader who combines people management with hands-on operational and field sales expertise: directing day-to-day execution, building scalable processes in advance of launch demand, and serving as the organization's subject matter expert on operations supporting regional congresses and peer-to-peer education. The role also supports planning and execution of national, area, and regional field meetings, including launch and plan-of-action meetings.
The Associate Director serves as a strategic and operational partner to Marketing, Sales Leadership, Medical Affairs, Legal, Compliance, Procurement, Finance, Accounts Payable, IT, and external agencies, establishing consistent ways of working and advancing continuous improvement across the U.S. National Portfolio Field Excellence organization. This is a non-demand-generating leadership role: it carries no sales quota and conducts no promotional activity with customers.
Key Responsibilities
- Lead, coach, and develop the program and operations team, setting priorities, service expectations, and accountability for execution.
- Lead U.S. promotional speaker bureau operations across portfolio brands, including speaker nomination, vetting, fair market value review coordination, contracting, onboarding, training logistics, recertification, and utilization monitoring.
- Manage speaker program systems and vendors, including field requests, approval workflows, attendee records, honoraria and expense payments, program closeout, and data readiness for Open Payments reporting.
- Plan and execute commercial regional congresses and sponsorships with Marketing, Sales Leadership, and Medical Affairs, including annual calendars, engagement plans, exhibits, field staffing, logistics, on-site operations, and follow-up.
- Manage national, area, and regional field meetings, including launch and plan-of-action meetings; coordinate timelines, logistics, and follow-through.
- Coordinate forums and activities that strengthen portfolio connectivity across field teams in support of shared customers, launches, and evolving commercial priorities.
- Own agency and supplier performance, scopes of work, program budgets, forecasts, accruals, reconciliation, and financial closeout in partnership with Procurement and Finance.
- Establish consistent processes for program intake, approvals, contracting, purchase orders, payments, and documentation; partner with Legal, Regulatory, and Compliance to maintain appropriate controls and practical guidance.
- Partner with Sales Operations & Analytics and IT on systems, workflows, data quality, and reporting; use program results and stakeholder feedback to resolve issues and improve execution.
- Support launch readiness and continuous improvement by building scalable processes, vendor capacity, job aids, and stakeholder training aligned with portfolio priorities.
- Travel approximately 25% for regional congresses, speaker training events, commercial meetings, and home office collaboration.
- Other duties as assigned.
Required Skills, Experience and Education
- Bachelor's degree required with at least 8 years of progressive experience in pharmaceutical or biotechnology sales, commercial operations, including speaker bureau and congress or event operations in partnership with brand marketing.
- Experience leading and developing program or operations professionals, with clear accountability for team priorities, execution, and performance.
- Experience managing agencies and suppliers, including RFPs, scopes of work, budgets, forecasting, accruals, and reconciliation.
- Working knowledge of speaker program and event management systems, or speaker bureau vendor platforms, and related CRM workflows and data flows.
- Strong understanding of U.S. pharmaceutical requirements and company controls governing promotional programs, HCP engagement, and commercial sponsorships.
- Demonstrated ability to improve cross-functional processes from design through implementation, stakeholder adoption, and measurement of results.
- Strong organizational, analytical, problem-solving, and project management skills, with the ability to manage competing priorities and use operational data to recommend action.
- Excellent written and verbal communication skills and the ability to influence cross-functional partners and translate complex requirements into practical guidance.
- Collaborative, detail-oriented, and comfortable building processes and managing ambiguity in a growing commercial organization.
Preferred Skills
- Oncology experience, including product launch or portfolio expansion.
- Experience planning and executing national, area, or regional sales meetings, including launch or plan-of-action meetings.
- Experience building commercial program processes and infrastructure from pre-launch through launch in a smaller, growing biotechnology company.
- Experience transitioning speaker bureau or congress operations between externally supported and internally managed models.
- Advanced degree or relevant process improvement or meeting management certification, such as Lean Six Sigma or Certified Meeting Professional (CMP).
Requirements
- Bachelor's degree required
- At least 8 years of progressive experience in pharmaceutical or biotechnology sales, commercial operations
- Experience with speaker bureau and congress or event operations in partnership with brand marketing
- Experience leading and developing program or operations professionals
- Experience managing agencies and suppliers, including RFPs, scopes of work, budgets, forecasting, accruals, and reconciliation
- Working knowledge of speaker program and event management systems or speaker bureau vendor platforms and related CRM workflows
- Strong understanding of U.S. pharmaceutical requirements and company controls governing promotional programs, HCP engagement, and commercial sponsorships
- Demonstrated ability to improve cross-functional processes from design through implementation
- Strong organizational, analytical, problem-solving, and project management skills
- Excellent written and verbal communication skills
- Collaborative, detail-oriented, comfortable managing ambiguity
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.